SCHEMBL7319468

SCHEMBL7319468

CC(=O)SCC(Cc1ccc(-c2ccccc2)cc1)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.51
MME P08473 13/20 0.50
ACE P12821 7/20 0.50
PPARA Q07869 2/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
ABCC3 O15438 1/20 0.50
NR1I2 O75469 1/20 0.50
ABCB11 O95342 1/20 0.50
NR3C1 P04150 1/20 0.50
RARG P13631 1/20 0.50
CNR1 P21554 1/20 0.50
OPRK1 P41145 1/20 0.50
NR1H2 P55055 1/20 0.50
NR1H3 Q13133 1/20 0.50
NR1I3 Q14994 1/20 0.50
SRR Q9GZT4 1/20 0.48
PSAT1 Q9Y617 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8861587 1.00 CYP1A2 (0.51) CYP1A2MMEACEPPARACYP3A4
SCHEMBL838962 0.91 CYP1A2 (0.63) CYP1A2MMEPPARACYP3A4CYP2D6
SCHEMBL838961 0.91 CYP1A2 (0.63) CYP1A2MMEPPARACYP3A4CYP2D6
SCHEMBL6154521 0.91 CYP1A2 (0.63) CYP1A2MMEPPARACYP3A4CYP2D6
Hydrochloric Acid SCHEMBL6572923 0.89 CYP1A2 (0.61) CYP1A2MMEPPARACYP3A4CYP2D6
Hydrochloric Acid SCHEMBL6572922 0.89 CYP1A2 (0.61) CYP1A2MMEPPARACYP3A4CYP2D6
SCHEMBL7319197 0.88 PPARA (0.48) CYP1A2MMEACEPPARACYP3A4
Benzoquinone SCHEMBL28513425 0.85 CYP1A2 (0.56) CYP1A2MMEPPARACYP3A4CYP2D6
SCHEMBL7435690 0.84 CYP1A2 (0.46) CYP1A2PPARACYP3A4CYP2D6CYP2C9
SCHEMBL6169549 0.84 MME (0.60) MMEACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110194731-B Mercaptopropionic acid amide compound, preparation method and medicinal application thereof 复旦大学 2021-05-04 CN disclosed
US-5846956-A Amino acids derivatives, the process for their preparation and their applications to therapy SOCIETE CIVILE BIOPROJET (FR) 1998-12-08 US disclosed
US-5670531-A ENKEPHALINASE OR ANGIOTENSIN CONVERTING ENZYME INHIBITORS SOCIETE CIVILE BIOPROJET (FR) 1997-09-23 US disclosed
US-5644055-A Antihypertensive tricyclic azepine derivatives useful as inhibitors of enkephalinase and ACE CIBA-GEIGY CORPORATION (US) 1997-07-01 US disclosed
US-5599951-A ENZYME INHIBITORS SOCIETE CIVILE BIOPROJET (FR) 1997-02-04 US disclosed
EP-0706525-A1 ANTIHYPERTENSIVE TRICYCLIC AZEPINE DERIVATIVES USEFUL AS INHIBITORS OF ENKEPHALINASE AND ACE Novartis AG (CH) 1996-04-17 EP disclosed
WO-1995001353-A1 ANTIHYPERTENSIVE TRICYCLIC AZEPINE DERIVATIVES USEFUL AS INHIBITORS OF ENKEPHALINASE AND ACE CIBA-GEIGY AG (CH) 1995-01-12 WO disclosed
US-5262436-A Administering; enzyme inhibitor SCHERING CORPORATION (US) 1993-11-16 US disclosed
EP-0566157-A1 Neutral metalloendopeptidase inhibitors in the treatment of hypertension SCHERING CORPORATION (US) 1993-10-20 EP disclosed
US-5061710-A Atrial natriuretic factors SCHERING CORPORATION (US) 1991-10-29 US disclosed
US-4929641-A DIURETICS, ANGIOTENSIN CONVERTING ENZYMES SCHERING CORPORATION (US) 1990-05-29 US disclosed
US-4801609-A Mercapto-acylamino acid antihypertensives SCHERING CORPORATION (US) 1989-01-31 US disclosed
EP-0254032-A2 Neutral metalloendopeptidase inhibitors in the treatment of hypertension SCHERING CORPORATION (US) 1988-01-27 EP disclosed